Modification of the Quality of Life Based on Objective Geriatric Tests

Overview

The analysis of this study will achieve an improvement in the management of patients over 70 years with adaptation of chemotherapy regimens after analysis of the subject and its psychosocial environment.

The analysis of socio-economic impacts will implement actions to optimize the care of the elderly while emphasizing the value of management / cost of care.

Full Title of Study: “Pilot Project – Prospective Longitudinal Cohort of Patients Over 70 Years With Malignant Solid Tumors: Modification of Quality of Life Based on Objective Geriatric Tests”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2019

Detailed Description

Quality of life is defined as "an individual's perception of his place in life, in the context of culture and value system in which he lives, in relation to its goals, expectations, standards and concerns "(WHO 1993).

This concept refers to multiple dimensions, both objective and subjective:

- The physical condition of the person, his functional abilities;

- His somatic sensations;

- His psychological health;

- His social status, relational environment.

This concept focuses on perception's basics. Quality of life is a criteria supposed to be objective even though it is subject to subjective interpretation at the highest point. Indeed, if the quality of life varies depending on the discretion of each person, it also changes over time: it refers to a situation at a given moment and not to a stable state.

Therefore in this study, it seemed appropriate to show the concept of "quality of life objective" which is linked to objective data measures recognized criteria for evaluating the elderly. These criteria are repeatable, validated and not dependent operator.

This process completely matches with the actions promoted by the 2009-2013 Cancer Plan (measures 23 and 26) on the basis of an improvement of:

- The quality of consideration of the psychosocial dimension (customization accompaniment, living environment, social, involvement, ..)

- The quality of the integration of physical and psychological dangers inherent to this weakness situation induced by cancer.

Interventions

  • Other: geriatric care and longitudinal follow up
    • geriatric care and longitudinal follow up

Arms, Groups and Cohorts

  • Other: A-Elderly patients with cancer
    • geriatric care and longitudinal follow up

Clinical Trial Outcome Measures

Primary Measures

  • Measuring quality of life according to geriatric questionnaires
    • Time Frame: 36 months
    • Activities of Daily Living Questionnaire

Secondary Measures

  • Geriatric Screening Test fragilities and comorbidities
    • Time Frame: 36 months
    • Mini Mental State Examination

Participating in This Clinical Trial

Inclusion Criteria

  • Patient over 70 years,
  • Patient with a solid malignant tumor,
  • Patients for whom a first line chemotherapy is theoretically indicated
  • Patient chemotherapy naive,
  • Performance Index (PS) <4

Exclusion Criteria

  • Patient not understanding or do not speak French,
  • Patients with any severe psychopathological disorder preventing the completion of the questionnaire or invalidating a priori measures of the questionnaire

Gender Eligibility: All

Minimum Age: 70 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Antoine Lacassagne
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • VĂ©ronique MARI, md, Principal Investigator, Centre Antoine Lacassagne

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.